开拓药业-B(09939) - 2023 - 年度财报

Independent Auditor's Report 122 獨立核數師報告 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限責任公司) Stock Code 股份代號 : 9939 Company Profile 2 公司簡介 Consolidated Statement of Changes in Equity 136 綜合權益變動表 Definitions and Glossary of Technical Terms 254 釋義及技術詞彙 Financial Highlights 9 財務摘要 Corporate Governance Report 70 企業管治報告 KINTOR PHARMACEUTICAL LIMITED ANNUAL REPORT 2023 2 GT0486 is an inhibitor of the PI3K/mTOR signalling pathway and a second generation mTOR inhibitor. We are currently d ...